(Q44590367)

4 December 2017

title

Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier (English)

1 reference

4 December 2017

Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood–brain barrier (English)

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(03)03227-X

12 March 2024

1 reference

Mona Boules

1

1 reference

4 December 2017

Beth McMahon

2

1 reference

4 December 2017

Rui Wang

3

1 reference

4 December 2017

Lewis Warrington

4

1 reference

4 December 2017

Jennifer Stewart

5

1 reference

4 December 2017

Sally Yerbury

6

1 reference

4 December 2017

Abdul Fauq

7

1 reference

4 December 2017

Daniel McCormick

8

1 reference

4 December 2017

Elliott Richelson

9

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

10 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14499944

full work available at URL

12 March 2024

https://api.elsevier.com/content/article/PII:S000689930303227X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(03)03227-X

https://api.elsevier.com/content/article/PII:S000689930303227X?httpAccept=text/plain

12 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(03)03227-X

12 March 2024

1 reference

4 December 2017

volume

987

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

39-48

1 reference

Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Effects of neurotensin on regional brain concentrations of dopamine, serotonin and their main metabolites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Tolerance to the hypothermic but not to the analgesic effect of [D-Trp11]neurotensin during the semichronic intracerebroventricular infusion of the peptide in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Receptor-receptor interactions in the central nervous system. A new integrative mechanism in synapses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Desensitization of neurotensin receptor-mediated cyclic GMP formation in neuroblastoma clone N1E-115

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Differential neurobehavioral effects of neurotensin and structural analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Does neurotensin mediate the effects of antipsychotic drugs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Neurotensin: central nervous system effects of a hypothalamic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Interactions of neurotensin with brain dopamine systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Elective tolerance to behavioral effects of neurotensin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Central administration of neurotensin stimulates hypothalamic-pituitary-adrenal activity. The paraventricular CRF neuron as a critical site of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Effects of thioproperazine and apomorphine on dopamine synthesis in the mesocortical dopaminergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Involvement of D1 and D2 dopamine systems in the behavioral effects of cocaine in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Neurotensin and neurotensin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Neurotensin reduces the affinity of D-2 dopamine receptors in rat striatal membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Neurotensin modulates the binding characteristics of dopamine D2 receptors in rat striatal membranes also following treatment with toluene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Intraventricular injection of neurotensin reduces the binding of dopamine D-2 receptors in the rat forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Neurotensin Decreases the Affinity of Dopamine D2Agonist Binding by a G Protein-Independent Mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

Further characterization of neurotensin receptor desensitization and down-regulation in clone N1E-115 neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

CNS drug design based on principles of blood-brain barrier transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903227-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Neurotensin analogs [D-TYR11] and [D-PHE11]neurotensin resist degradation by brain peptidases in vitro and in vivo

6

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(03)03227-X

12 March 2024

Identifiers

1 reference

4 December 2017

1 reference